Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sytske Anne Bergstra

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Rheumatology (Oxford, England)|September 12, 2018
Autoantibody status is not associated with early treatment response to first-line methotrexate in patients with early rheumatoid arthritisJacqueline S Dekkers, Sytske Anne Bergstra, Arvind Chopra, et al.
Clinical Rheumatology|March 9, 2026
Global patterns and predictors of initial treatment in early rheumatoid arthritis: insights from a multinational machine learning studyDavid Vega-Morales, Pedro Machado, Sytske Anne Bergstra, et al.
Rheumatology (Oxford, England)|February 23, 2018
TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 yearsMarieke Loef, Féline P B Kroon, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases|August 31, 2021
Joint inflammation tends to recur in the same joints during the rheumatoid arthritis disease courseSascha L Heckert, Sytske Anne Bergstra, Xanthe M E Matthijssen, et al.
Annals of the Rheumatic Diseases|November 18, 2023
Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohortSascha Louise Heckert, Johanna Maria Maassen, S le Cessie, et al.
RMD Open|May 31, 2020
Earlier is better when treating rheumatoid arthritis: but can we detect a window of opportunity?Sytske Anne Bergstra, Joy A Van Der Pol, Naghmeh Riyazi, et al.
Journal of Scleroderma and Related Disorders|September 25, 2023
The long-term course of the Health Assessment Questionnaire in patients with systemic sclerosisSophie Ie Liem, Sytske Anne Bergstra, Jacopo Ciaffi, et al.
Annals of the Rheumatic Diseases|December 16, 2022
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritisLotte van Ouwerkerk, Maarten Boers, Paul Emery, et al.
Rheumatology (Oxford, England)|April 20, 2022
The effect of silver fibre gloves on Raynaud's phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trialSophie I E Liem, Eva M Hoekstra, Femke Bonte-Mineur, et al.
RMD Open|January 7, 2023
Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatmentSascha L Heckert, Sytske Anne Bergstra, Yvonne P M Goekoop-Ruiterman, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Rheumatology (Oxford, England)|September 12, 2018
Autoantibody status is not associated with early treatment response to first-line methotrexate in patients with early rheumatoid arthritisJacqueline S Dekkers, Sytske Anne Bergstra, Arvind Chopra, et al.
Clinical Rheumatology|March 9, 2026
Global patterns and predictors of initial treatment in early rheumatoid arthritis: insights from a multinational machine learning studyDavid Vega-Morales, Pedro Machado, Sytske Anne Bergstra, et al.
Rheumatology (Oxford, England)|February 23, 2018
TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 yearsMarieke Loef, Féline P B Kroon, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases|August 31, 2021
Joint inflammation tends to recur in the same joints during the rheumatoid arthritis disease courseSascha L Heckert, Sytske Anne Bergstra, Xanthe M E Matthijssen, et al.
Annals of the Rheumatic Diseases|November 18, 2023
Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohortSascha Louise Heckert, Johanna Maria Maassen, S le Cessie, et al.
RMD Open|May 31, 2020
Earlier is better when treating rheumatoid arthritis: but can we detect a window of opportunity?Sytske Anne Bergstra, Joy A Van Der Pol, Naghmeh Riyazi, et al.
Journal of Scleroderma and Related Disorders|September 25, 2023
The long-term course of the Health Assessment Questionnaire in patients with systemic sclerosisSophie Ie Liem, Sytske Anne Bergstra, Jacopo Ciaffi, et al.
Annals of the Rheumatic Diseases|December 16, 2022
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritisLotte van Ouwerkerk, Maarten Boers, Paul Emery, et al.
Rheumatology (Oxford, England)|April 20, 2022
The effect of silver fibre gloves on Raynaud's phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trialSophie I E Liem, Eva M Hoekstra, Femke Bonte-Mineur, et al.
RMD Open|January 7, 2023
Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatmentSascha L Heckert, Sytske Anne Bergstra, Yvonne P M Goekoop-Ruiterman, et al.
Pageof 6